Several preclinical studies have shown that HOTTIP can be used as a possible marker for the early diagnosis of CRC [551], as a drug response prediction marker [552], as a predictive marker of risk, and as a prognostic marker [553]. This evidence concerns the gene HOTTIP and colorectal carcinoma.